Filing Details
- Accession Number:
- 0001213900-21-014908
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-11 17:36:46
- Reporting Period:
- 2021-03-09
- Accepted Time:
- 2021-03-11 17:36:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1218683 | Wize Pharma Inc. | WIZP | Pharmaceutical Preparations (2834) | 880445167 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1720898 | Noam Danenberg | C/O Wize Pharma, Inc. 24 Hanagar Street Hod Hasharon L3 4527708 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2021-03-09 | 2,916,667 | $0.12 | 3,165,705 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
